Advertise in C&EN's Special Issue on
The Future of Pharma/Biotech
Reach Over 300,000 Key Decision Makers Worldwide C&EN looks a decade ahead for a critical analysis of the state of the industry, science, and regulatory environment for the pharma/biotech industry. The issue focuses on:
Business Personalized medicine's impact on drug development Feasibility of double-digit earnings growth in pharma Pricing and U.S. global leadership in R&D costs
Science Progress toward overcoming key bottlenecks in drug development Impact on R&D of systems biology, proteomics, genomics, medicinal chemistry, computational chemists and other disciplines
Government Regulations Evolution of the U.S. regulatory climate I FDA drug approval process & the conduct of clinical trials Contact your C&EN representative ( 6 1 0 ) 9 6 4 - 8 0 6 1 o r e - m a i l d o n a t O @ a c s . o r g .
Don't Forget! · Issue date: 6 / 1 9 / 0 6 · Ad closing date: 6 / 5 / 0 6
CHEMICAL & Engineering News
